Skip to content Skip to navigation

Biomaterials & Devices

CCRM develops biomaterials and human tissue mimetics for functional tissue drug screening, in vitro and in vivo cell modulation, endogenous stem cell stimulation, stem cell delivery and cell therapy development.

Biomaterials & Devices Capabilities


  • Biomedical polymer processing (porous scaffolds, fibres, coatings, micro/nano-spheres, hydrogels)
  • Surface modification
  • Combination products (polymers + cells, drugs, biomolecules)
  • Design documentation
Materials selection
  • Regulatory history assessment
  • Cost analysis
  • Sourcing
  • Purity analysis
  • Material substitution and equivalency testing
Product and process development
  • Feasibility assessment (COGs & unit operations analysis)
  • Scale-up (equipment selection, reagent acquisition, batch production & testing)
  • Optimization (yield, purity, cost)
  • Pilot scale production for technology transfer
  • Analytical method development
  • Process standardization and validation
Prototype/clinical sample fabrication
  • Controlled environment (class 10,000 cleanroom)
  • Cell culture
  • Stability & biocompatibility testing
  • Specialized device testing
  • Final product specification testing development & validation
  • Technical file documentation
Custom polymer synthesis
  • Bulk, solution, suspension & emulsion polymerizations
  • Stable and degradable polymers
  • Physicochemical characterization